Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERENUMAB-AOOE Cause Small intestinal obstruction? 14 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Small intestinal obstruction have been filed in association with ERENUMAB-AOOE. This represents 0.0% of all adverse event reports for ERENUMAB-AOOE.

14
Reports of Small intestinal obstruction with ERENUMAB-AOOE
0.0%
of all ERENUMAB-AOOE reports
0
Deaths
7
Hospitalizations

How Dangerous Is Small intestinal obstruction From ERENUMAB-AOOE?

Of the 14 reports, 7 (50.0%) required hospitalization.

Is Small intestinal obstruction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERENUMAB-AOOE. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does ERENUMAB-AOOE Cause?

Accidental exposure to product (9,923) Device difficult to use (9,530) Wrong technique in product usage process (9,359) Drug dose omission by device (6,340) Migraine (4,290) Drug ineffective (3,813) Constipation (3,104) Product storage error (2,958) Headache (2,787) Injection site pain (2,715)

What Other Drugs Cause Small intestinal obstruction?

ADALIMUMAB (1,665) INFLIXIMAB (351) VEDOLIZUMAB (341) BEVACIZUMAB (268) RISANKIZUMAB-RZAA (241) DOXORUBICIN (237) CLOZAPINE (211) PREDNISONE (190) CARBOPLATIN (178) FLUOROURACIL (178)

Which ERENUMAB-AOOE Alternatives Have Lower Small intestinal obstruction Risk?

ERENUMAB-AOOE vs ERENUMAB\ERENUMAB-AOOE ERENUMAB-AOOE vs ERGOCALCIFEROL ERENUMAB-AOOE vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL ERENUMAB-AOOE vs ERIBULIN ERENUMAB-AOOE vs ERLOTINIB

Related Pages

ERENUMAB-AOOE Full Profile All Small intestinal obstruction Reports All Drugs Causing Small intestinal obstruction ERENUMAB-AOOE Demographics